The Mumbai-based drug firm has launched Empagliflozin, a widely recognised SGLT2 inhibitor, under the brand name Glempa (Empagliflozin 10/25 mg), along with its fixed-dose combinations ...
Mar 16, 2025 11:05 Glenmark Launches Empagliflozin for Diabetes in India Glenmark Pharmaceuticals launches Empagliflozin, an SGLT2 inhibitor, in India under the brand name Glempa for glycemic control ...
Mar 13, 2025 14:25 Glenmark Launches Empagliflozin for Diabetes in India Glenmark Pharmaceuticals launches Empagliflozin, an SGLT2 inhibitor, in India under the brand name Glempa for glycemic control ...
Reportedly, there will be two models in the series, both powered by its Exynos 1580 chipset. The FE series is expected to be cost-effective compared to the Galaxy Tab S10 series ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback